Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$SRNE is not just a COVID play. Sorrento also has cancer drugs and pain drugs. I can not believe that people short this stock. Keep in mind that SRNE pain drug should have phase 3 results in 2021. If they are good that will be huge. Keep in mind that there is risk in SRNE so make certain you do proper research before investing.
SCILEX HOLDING COMPANY (“Scilex”) , a majority-owned subsidiary of Sorrento, is dedicated to the development and commercialization of pain management products. The company’s lead product ZTlido® (lidocaine topical system 1.8%), is a branded prescription lidocaine topical product approved by the U.S. Food and Drug Administration for the relief of pain associated with Post-Herpetic Neuralgia (PHN), which is a form of post-shingles nerve pain.
Scilex’s SP-102 (10 mg dexamethasone sodium phosphate gel), or SEMDEXA™, for the treatment of Lumbar Radicular Pain is in the process of completing a Phase III clinical trial. The company expects SP-102 to be the first FDA approved non-opioid epidural injection to treat lumbosacral radicular pain, or sciatica, with the potential to replace 10 to 11 million off-label epidural steroid injections administered each year in the US.
[https://clinicaltrials.gov/ct2/show/NCT03372161?term=SP-102&draw=2&rank=2](https://clinicaltrials.gov/ct2/show/NCT03372161?term=SP-102&draw=2&rank=2)
Almost green in AH now :)
Yes that is possible as well. Think we just need to be patience and then we will be rewarded .
My $SRNE shares is not for sale...
Please note also:
This is the first FDA clearance of a clinical trial of intranasal administration of a neutralizing antibody against the SARS-CoV-2 virus.
$SRNE have other COVID-19 products that is closed to get on market.
Example covi-stix and also please note corona is here for long time.
I look for getting back in @ low 20’s
Sorry mispelled Fress
Me 2.. Frees is still with us as well for sure..
$THCB
is worth between $20.92 and $30.15 per share based on its comps and projections, at least 26% to 80% more than its present price.
https://investorplace.com/2021/03/thcb-stock-is-worth-between-20-92-and-30-15-based-on-comps-and-forecasts/
Hope he will buy on the ask :).
Copied from Stocktwits
https://charts.stocktwits.com/production/original_296998139.png
On Microvast's investor presentation, they confirmed 9 customer partnerships, and 3 R&D partners. I'm going to discuss a few of them...
On the conference call transcript (6), " Microvast is also in advanced discussions with two other marquee global customers which, if executed, could provide an additional $3 billion in contracted revenue through 2028" I think I figured out who one of them is going to be, but WTF do I know?
Disclosure and disclaimer: not a stonk advisor, do your own DD, I have 8000 warrants and 1000 shares
OSHKOSH CORP ($OSK)
Oshkosh is a specialty vehicle producer. They have billions in contracts with the government, and have 9 brands that they own. These brands include military vehicles, consruction vehicles, garbage trucks, firetrucks, and a few more you can read about at (1).
What makes Oshkosh special as a partner is that they invested $25M in THCB via PIPE and announced a Joint Development Agreement. A JDA is when 2 firms work on project(s) together. I believe that this project is the USPS vehicle, and that is one of the primary purposes of the new facility in TN (For Microvast).
Oshkosh will also be producing EV garbage trucks in 2021. There isn't much info on this on the internet, other than (2) so I can't say for certain that they will be using Microvast. However, if they are in 2021, then Oshkosh would be importing batteries from the Chinese factory in the meantime. If that is economically feasible, this could open many doors for OSK.
If the government is planning on "electrifying their entire fleet" then they can utilize OSK MVST capabilities. This is why "In 2019, at the request of the U.S. Department of Energy (DOE), Microvast began the process of establishing a Li-ion battery facility in the United States", according to TN,GOV (3)
FPT Industrial/ Iveco Bus/ CNH Industrial
These three companies are all own under CNH. Microvast Signed industrial and commercial cooperation agreement with FPT Industrial (“FPT”), the global powertrain brand of CNH Industrial Group, in 2020. This enables FPT to "design and assemble battery packs in house in Italy". This is their main source of contracted revenue, which goes out until 2025-2027.
The investor presentation contained some products that they were going to produce together. It's not on the investor presentation now as they changed it, but luckily I have a screen shot haha.
Excerpt from IP before mgmt changed it
ARGONNE NATIONAL LABRATORY (the DOE)
Argonne is a U.S department of energy multidisciplinary science and engineering research center, where talented scientists and engineers work together to answer the biggest questions facing humanity, from how to obtain affordable clean energy to protecting ourselves and our environment. (4) As I previously stated that the US DOE requested Microvast builds in the USA, this just further validates that they are working with the Government. I think there will be a lot of collaboration with the gov and Microvast (like the USPS contracted that I predicted), and we will benefit immensely and be a significant part of electrify the government fleet of vehicles.
FORD, and USCAR (Owned by Ford, GM, and Chrystler)
The investor presentation confirmed Ford as an R&D partner. We were all aware that Ford and Microvast have been working together as they entered a 3-year contract in March 2020 (5). We have all read about Ford and their shitty battery partner. I think Ford will be 1 of the 2 marquee customers that mgmt has identified in the potential $3B pipeline.
I think Microvast and Ford will enter a contract similar to the one with FPT. If Microvast allows Ford to use their patents and some of their staff, they can output batteries at a much higher rate. They may also announce another factory (maybe in TX?) where they can supply Ford and other car manufacturers. This is speculation^
On Ford's last conference call, the CEO said they are in advanced talks with a battery supplier. Ford is also "committing $29B to EV" (7) and "100% electric in Europe in 2030" (8). Their european HQ is in Germany, a few hundred miles away from Microvast.
TLDR Microvast has multiple partners that can mass produce vehicles. Oshkosh and Ford are 100 year old+ vehicle manufacturers that can seriously contribute to the electrification of the USA. This is one of the main thesis' of investing in Microvast. If Microvast continues to up their product capabilities, they too will achieve economies of scale and out cost and therefore beat their competition. I've never been so bullish on something and I am all in! I like the stock!
(1) https://www.oshkoshcorp.com/en/brands-innovations
(2) https://moneymorning.com/2021/02/24/oshkosh-stock-is-an-even-stronger-buy-after-its-6-billion-usps-contract/
(3) https://www.tn.gov/ecd/news/2021/2/10/governor-lee--commissioner-rolfe-announce-microvast-to-establish-manufacturing-facility-in-clarksville.html
(4) https://www.anl.gov/argonne-national-laboratory
(5) http://www.uscar.org/guest/news/1004/News-Release-USABC-AWARDS-4-5-MILLION-CONTRACT-TO-MICROVAST-FOR-DEVELOPMENT-OF-LOW-COST-FAST-CHARGE-BATTERIES-FOR-ELECTRIC-VEHICLE-APPLICATIONS
(6) http://www.microvast.com/upload/2021/02/12/161314009474182dgvj.pdf
(7) https://www.caranddriver.com/news/a35432253/ford-ev-commitment-announced/
(8) https://www.forbes.com/sites/michaeltaylor/2021/02/17/ford-europe-commits-to-ev-only-future-first-car-due-in-2023/?sh=2cfefc0933eb
DD from : u/Puts_on_you
What makes up Ideanomics?
Delaware Board of Trade (DBOT): IDEX is majority stakeholders in DBOT. DBOT is an exchange for equities not listed in the NYSE or Nasdaq.
Intelligenta: AI-driven financial service that helps clients make better decisions, manage their risk, and focus on the efficiencies that drive ROI
Liquefy: Stakeholders of Liquefy. Their primary focus is tokenizing illiquid assets like real estate. Looking to expand into exotic spaces such as horse racing and sports teams.
Logistorm: Focus on using smart tech to make industrial manufacturing more efficient.
Solectrac: First North American Company to offer 100% battery-powered tractors.
Timios: Company focused on simplifying the real estate process for buyers, sellers, and professionals. Making it stress-free.
Treeletrik: [/b]EV company that brought the first true electric bike to Malaysia and is the only licensed EV manufacturer there. When IDEX took a controlling stake, they were able to extend Treeletrik's portfolio from EV Mopeds and Bikes to EV buses, trucks, cars, and light rail. These products serve 650M people in the ASEAN region.
WAVE: Leading provider of EV charging solutions for medium and heavy-duty EVS. Have a hands-free charging system that eliminates battery range limitations. They can be used at charging stations embedded in roadways allowing vehicles to make scheduled stops.
MEG Latest Earnings: In Q4 of 2020 they delivered 706 units, 439 of which in December alone. Q4 deliveries also included 13 bus battery systems and 1 charging system.
$IDEX play @ 13:04 in the video...
H.C. Wainwright Maintains Their Buy Rating on Pulmatrix (PULM)
https://www.analystratings.com/articles/h-c-wainwright-maintains-their-buy-rating-on-pulmatrix-pulm/
PULM is a long term hold. Cost of Lung cancer treatments cost £2.4B a Year and How Covid has increased the number of people who will have respiratory diseases.
Any type of lung cancer is devastating. According to cancer research UK, the annual cost of lung cancer is over £2B. And in the US, the cost of a single patient treatment is between $10,000 - $15000.
How does COVID-19 affect the overall respiratory system?
COVID-19 can affect the respiratory system in a variety of ways and across a spectrum of levels of disease severity, depending on a person’s immune system, age and comorbidities. Symptoms can range from mild, such as cough, shortness of breath and fevers, to critical disease, including respiratory failure, shock and multi-organ system failure.
Respiratory issues are growing faster than ever due to Covid. The long term effects of Covid include respiratory symptoms and conditions such as chronic cough, shortness of breath, lung inflammation and fibrosis, and pulmonary vascular disease. With more and more people recovering from Covid, there are more people who are going to be at severe risk to respiratory problems. This makes PULM a huge player for the future, as there is going to be a huge demand for respiratory treatment. This is where PULM comes in and will be able to deliver effective treatments to treat respiratory problems in the future.This indicates how PULM is a long term investment and not a quick swing trade due to the “public offering”.
From UCHealth it states:
“Can COVID-19 cause permanent lung damage? For those who have underlying health conditions, what does long-term lung damage mean for them?
Yes, it's possible and perhaps likely that people with chronic lung injury are at higher risk of long-term complications. We don't know, but data from severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS) suggests that as many as 50% of people who have had COVID-19 may have some lung damage. “
Let’s do some Maths. Let’s say 50% of people who have had Covid have respiratory problems in the future. In total there have been 111M cases with 62.4M people who have recovered fully and 2.45M deaths worldwide. Just in the US there has been 28M cases. If 50% contract respiratory problems in the future this leads to an additional 14M people on top of the current 25M people in the US who already have respiratory problems. That gives a grand total of 39M people who will/have respiratory problems. This indicates the huge market PULM has to target in the future and how PULM will be able to grow revenues significantly.
More info is posted on r/PULM
Also make sure you check out:
https://www.reddit.com/r/pennystocks/comments/lnj1nh/indepth_dd_on_pulm_biopharma_pennystock/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
PULM : Financial Due Diligence
Preface: I am NOT a financial advisor
Background: B.S. Accounting
Summary: I consider PULM to still be undervalued according to the financials
source: [https://www.morningstar.com/stocks/xnas/pulm/financials](https://www.morningstar.com/stocks/xnas/pulm/financials)
The good:
* Good financial health and has the ability to cover its debts
* Quick Ratio: 3.38 (Above 1 is normally considered good)
* Current Ratio: 3.51 (Has the ability to easily cover all current debts; A/P, etc)
* High Revenue Growth
* Seen dramatic climb in revenue over last 3 years
* 2017: .34mil
* 2018: .15 Mil
* 2019: **7.91** Mil
* TTM: **12.32** Mil
* 111.59% increase
* Increased Profitability
* Also included in the Bad
* While posting higher operating income (linked to gross profit), they are still posting a loss year-to-year
* Increases to R&D
* 28.5% increase over the last 3 years. TTM shows a 40%+ increase to the budget.
* This is a personal metric I monitor in companies, I find that companies that have a strong focus on R&D tend to perform better.
The Meh:
* P/B value is 2.71; Depending on the investor this can be seen as good or bad. However it is considered to be on the lower side of penny stocks (the lower the P/B value, typically the more undervalued, I use sub 3 p/b value as an indicator of undervaluing).
The Bad:
* Low (negative) Profitability
* ROA: -53.9%
* ROE: -107%
* Net Margin: -166%
* However, profitability is not always considered in evaluating a company, however, it is important to consider it when investing in a company.
* High P/S Ratio
* 3.72
* This ratio compares how much investors put into how much the company produces in sales. The lower the ratio, the better for investors. Typically a good range is between 1-2 depending on the industry.
Moderate-to-good potential growth, however, will probably not hit above $10 a share for a long while IMO. However, I've been wrong many time before.
I personally have it as a price target of $6.50 by end of the year
Source:
U/OnlyAnAccountant
Info on all big buyers this month including offering
https://stocktwits.com/Vudu2022/message/295830737 https://stocktwits.com/Vudu2022/message/295830737
Check it ?? ??
SALE ON PULM TODAY! ONLY: 1.48-1.54 - GREAT PRICE!
Sale om PULM today - get it while it's cheap!
Institutions are increasing their positions:
https://insider-analysis.com/search_whales.php?ticker=TABLE_SRNE
Thanks for sharing. Very good Outlook for march...
MPS Is $INVA, but not really anything to do with SRNE or am i wrong ?
Thanks for sharing that very interesting.
I hope we find out soon. Patience is keywords in $SRNE... Long term will pay.
Sorrento isn't always Sorrento. Look at the link. They have subsidiaries or have other agreements in place. This is why I added more $SRNE today....
https://investors.sorrentotherapeutics.com/node/11826/html#tm212734d1_ex99-1.htm
HOLD
The institutional boys need to cover on other too. SRNE is on the list. HOLD
Sorrento Therapeutics Inc
Short Interest 23.09% Float 251.63M Shares
Outstanding 272.94M
Biotechnology & Medical Research
I Think the stix is aprooved in EU
https://charts.stocktwits.com/production/original_295823095.jpg
Added om dip again today $PULM
$SRNE community on Reddit trying to force short to cover and setting sell order @ $200 please help lets do it!!!
Thanks for explaining that to me :)
Have a nice day.
Nice. I am from Denmark and with my broker I can only buy the shares in $HYLN.
How does it works with the options , does it affect the share price when you buy/sell options in HYLN or ?
Added more shares again today $HYLN
$THCB - Microvast - What I believe to be a hugely undervalued EV play
DD (New Claims/Info)
Microvast DD
THCB is a Special Purpose Acquisition Company (SPAC). The price peaked yesterday on Feb 23rd and has dropped back to the $17-$18 level today. I have decided to share my detailed Due Diligence where I’ve touched on a number of key points and made my argument as to why the Reward outweighs the Risk with investment in this SPAC.
TUSCAN HOLDINGS $THCB
Tuscan Holdings has signed a Definitive Agreement to merge with Microvast.
The CEO Stephen Vogel is a very successful businessman and has a lot of experience with acquisition companies. Notably he was executive chairman at Forum merger Corp and Chief Financial Officer & Director at Subversive Capital Acquisition Corp.
The overall valuation of the deal was at $3b (when the stock was at $10) so the valuation is currently between 5b-6b
MICROVAST
Founded in 2006 Microvast have established themselves as market leader in the development and manufacture of fast charging, long-Life battery systems with superior safety for electric vehicles.
Microvast's batteries have supplied a range of e-buses, vans, trucks, passenger vehicles, automated guided vehicles, forklifts, and mining trucks. The company has installed batteries in 28,000 vehicles globally and even supplied buses at the 2018 Seoul winter Olympic Games. This international exposure puts Microvast at the top teir of EV suppliers.
Figure 1-Microvast worldwide application
They have recently released information on a new fast charging battery (HnCO-AH) with a high energy density of 265Wh/kg giving a decisive competitive advantage over current cells for the commercial vehicle sector that have an average density of 240Wh/kg.
in July 2020, Microvast completed construction on a production facility in Ludwigsfelde, Germany (close to potential future clients such as Mercedes-Benzes). The company said it plans to start production in March 2021 to begin making the new battery modules and packs for European customers. Recently the company has posted 77 new jobs for this facility.
Figure 2- Microvast German facility plan
In its new plant, Microvast is expected to put together parts made by the company's manufacturing facility in China. At first, the production capacity for the new factory is expected to be 1.5 GWh per year. However, it is expected to ramp up to 6 GWh per year with 250 employees. The new German facility will also function as a research facility and the company’s European headquarters. Microvast said it had invested approximately 50 million euros in the project.
The company have received credit from the prestigious R&D100 awards for their pioneering design of battery components optimized for high performance and uncompromising safety. This award undoubtedly lead to the United States Advanced Battery Consortium LLC (USABC), a subsidiary of the United States Council for Automotive Research LLC (USCAR), and a collaborative organization of FCA US LLC, Ford Motor Company and General Motors, to announce a $4.5 million contract to Microvast to lead a program to develop low-cost/fast-charge batteries for electric vehicle application.
Partnership with Oshkosh
Microvast currently exists as a private company and it is still a relative unknown as to how the company is performing financially. The CEO Yang Wu however stated the company expects to generate more than $100 million in revenue in 2020.
Investor presentation
http://www.microvast.com/upload/2021/02/05/16125326719819fmnxa.pdfhttp://www.microvast.com/upload/2021/02/05/16125326719819fmnxa.pdf
Have a look at their latest investor presentation which talks about their tech, future pipeline, and plans for the future. It's truly remarkable stuff.
Why buy $THCB
There are a number of reasons why I think THCB is a good buy. At current prices
THCB and Microvast tick several boxes.
EV Battery play (EV hype). QS who won't have a product until 2025, is valued way higher than THCB currently is.
Multinational company with 2 factories in China and one nearing completion in Germany, hoping to start production in Spring.
Amazing technology with recognition from the prestigious R&D100 awards for its new high density and safe battery.
Projected revenue's of $100m for 2020 (Big positive, SPAC company that has established supply chain and revenue)
low public float (27M shares) with 75.69% institutional holdings and 20.85% insiders. There is also touted to be overwhelming interest in this SPAC in Asia (China, Japan, South Korea) by all accounts, and if true, Chinese hedge funds will make this parabolic on ticker change. (this basically means demand > Supply for shares).
Microvast as a company have a high projected growth rate which will be accelerated with capital from merger.
Partnership with Oshkosh who just received the contract to build USPS delivery fleet. (yes the contract that WKHS was pumping on).
Conclusions
Microvast has a excellent product already in production and are generating revenues, this gives it huge upside potential in the short-term.
Long term I can see the company expanding production into the states given the interest shown from the USABC and has the potential of forming partnerships with several big automakers, especially now with the factory in Germany. This has already started with the partnership with Oshkosh who won the contract with the USPS.
At current prices I think this is a steal hence I have decided to share all this information with you. IMO this is the best opportunity I've seen in the market in years. I'm excited to have a huge amount of my portfolio in this.
Good luck all, I would appreciate any feedback or other information regarding THCB or Microvast I may have missed and you feel is important.
EDIT: THIS COMPANY HAS 43% SHORT FLOAT CURRENTLY
.
Links
https://www.bloomberg.com/news/articles/2020-11-12/microvast-is-said-in-talks-to-go-public-via-tuscan-spac-merger
https://moneymorning.com/2020/12/15/is-microvast-stock-a-buy-after-its-spac-deal/
https://www.electrive.com/2020/12/18/microvast-announces-fast-charging-utility-vehicle-battery/
https://www.azom.com/article.aspx?ArticleID=19793
http://microvast.com/index.php/news/info/109
https://auto.economictimes.indiatimes.com/news/auto-components/ev-battery-maker-microvast-to-go-public-through-spac-merger/79218830#:~:text=Microvast%2C%20whose%20batteries%20powered%20the,Wu%20said%20in%20a%20statement.
https://uk.finance.yahoo.com/quote/THCB/holders?p=THCB
https://spacinsider.com/stats/
Source #r/epicDD